Table of Contents

company-logo

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

AIM ImmunoTech Dividend Announcement

• AIM ImmunoTech does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on AIM ImmunoTech dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AIM ImmunoTech Dividend History

AIM ImmunoTech Dividend Yield

AIM ImmunoTech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AIM ImmunoTech stock? Use our calculator to estimate your expected dividend yield:

AIM ImmunoTech Financial Ratios

P/E ratio-0.44
PEG ratio-0.02
P/B ratio2.00
ROE-256.33%
Payout ratio0.00%
Current ratio1.17
Quick ratio1.17
Cash Ratio0.40

AIM ImmunoTech Dividend FAQ

Does AIM ImmunoTech stock pay dividends?
AIM ImmunoTech does not currently pay dividends to its shareholders.
Has AIM ImmunoTech ever paid a dividend?
No, AIM ImmunoTech has no a history of paying dividends to its shareholders. AIM ImmunoTech is not known for its dividend payments.
Why doesn't AIM ImmunoTech pay dividends?
There are several potential reasons why AIM ImmunoTech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AIM ImmunoTech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AIM ImmunoTech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AIM ImmunoTech a dividend aristocrat?
AIM ImmunoTech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AIM ImmunoTech a dividend king?
AIM ImmunoTech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AIM ImmunoTech a dividend stock?
No, AIM ImmunoTech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AIM ImmunoTech stocks?
To buy AIM ImmunoTech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AIM ImmunoTech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.